Advanced search
Publication Cover
Ultrastructural Pathology Volume 18, 1994 - Issue 1-2
Submit an article Journal homepage
65
Views
66
CrossRef citations to date
0
Altmetric
Original Article

Assessment of Anthracycline Cardiomyopathy by Endomyocardial Biopsy

Bruce Mackay Departments of Pathology, Medical Specialties, Diagnostic Radiology, and Medical Oncology, University of Texas MD. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA
,
Michael S. Ewer Departments of Pathology, Medical Specialties, Diagnostic Radiology, and Medical Oncology, University of Texas MD. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA
,
C. Humberto Carrasco Departments of Pathology, Medical Specialties, Diagnostic Radiology, and Medical Oncology, University of Texas MD. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA
&
Robert S. Benjamin Departments of Pathology, Medical Specialties, Diagnostic Radiology, and Medical Oncology, University of Texas MD. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA
Pages 203-211 | Published online: 10 Jul 2009

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Guido Giordano, Alessia Spagnuolo, Nunzio Olivieri, Claudia Corbo, Angelo Campagna, Ilaria Spagnoletti, Roberta Maria Pennacchio, Serena Campidoglio, Massimo Pancione, Luciano Palladino, Bruno Villari & Antonio Febbraro. (2016) Cancer drug related cardiotoxicity during breast cancer treatment. Expert Opinion on Drug Safety 15:8, pages 1063-1074.
Read now
Iain RJ Macpherson & TR Jeffry Evans. (2009) New approaches in the management of advanced breast cancer – role of combination treatment with liposomal doxorubicin. Breast Cancer: Targets and Therapy 1, pages 1-18.
Read now
Atiar M Rahman, Syed Wamique Yusuf & Michael S Ewer. (2007) Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. International Journal of Nanomedicine 2:4, pages 567-583.
Read now
Nelson G. Ordóñez & Bruce Mackay. (1998) Alveolar Soft-Part Sarcoma: A Review of the Pathology and Histogenesis. Ultrastructural Pathology 22:4, pages 275-292.
Read now

Articles from other publishers (62)

Michael S. Ewer, Syed Wamique Yusuf, Reto Asmis & Jun-ichi Abe. (2023) Editorial: Case reports in cardio-oncology: 2022. Frontiers in Cardiovascular Medicine 10.
Crossref
Michael S. Ewer, Steven M. Ewer & Thomas M. Suter. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 23 .
Maxime Caru & Daniel Curnier. (2022) The pediatric oncology exercise field speeds up to address important issues regarding chemotherapy-related cardiotoxicity. Frontiers in Pediatrics 10.
Crossref
Fatemeh Jafari, Afsane Maddah Safaei, Leila Hosseini, Sanaz Asadian, Tara Molanaie Kamangar, Fatemeh Zadehbagheri & Nahid Rezaeian. (2020) The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review. Heart Failure Reviews 26:3, pages 679-697.
Crossref
Shishir Upadhyay, Kunj Bihari Gupta, Anil Kumar Mantha & Monisha Dhiman. (2020) A short review: Doxorubicin and its effect on cardiac proteins. Journal of Cellular Biochemistry 122:2, pages 153-165.
Crossref
Saad Ghafoor, Marshay James, Jason Goldberg & Jennifer A. McArthur. 2019. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient 211 235 .
. 2018. Diagnostic Pathology: Cardiovascular. Diagnostic Pathology: Cardiovascular 34 35 .
I. Brana, E. Zamora, G. Oristrell & J. Tabernero. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 367 406 .
Takehiro Nakahara, Takashi Tanimoto, Artiom D. Petrov, Kiyotake Ishikawa, H. William Strauss & Jagat Narula. 2018. Experimental Models of Cardiovascular Diseases. Experimental Models of Cardiovascular Diseases 221 232 .
Marianne K. O. Grant, Davis M. Seelig, Leslie C. Sharkey & Beshay N. Zordoky. (2017) Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice. Biology of Sex Differences 8:1.
Crossref
Michael S. Ewer, Steven M. Ewer & Thomas Suter. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine 1 21 .
D. Kerkhove, I. Paciolla & G. Arpino. 2017. Anti-Cancer Treatments and Cardiotoxicity. Anti-Cancer Treatments and Cardiotoxicity 13 34 .
Sergio Barros-Gomes, Joerg Herrmann, Sharon L. Mulvagh, Amir Lerman, Grace Lin & Hector R. Villarraga. (2016) Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology 2:1.
Crossref
Ronald G. Schwartz & Nicholas Venci. (2015) Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?. Journal of Nuclear Cardiology 23:4, pages 833-836.
Crossref
Rosa Anna Manno, Andrea Grassetti, Germano Oberto, Abraham Nyska & Yuval Ramot. (2016) The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity. Journal of Applied Toxicology 36:8, pages 1060-1072.
Crossref
G. Dumas & E. Canet. (2016) Effets cardiovasculaires graves des chimiothérapies, thérapies ciblées et des traitements immunosuppresseursCardiovascular toxicity due to chemotherapy, targeted therapies, and immunosuppressive drugs: a narrative review. Réanimation 25:S3, pages 123-136.
Crossref
Graeme J. Koelwyn, Nia C. Lewis, Susan L. Ellard, Lee W. Jones, Jinelle C. Gelinas, J. Douglass Rolf, Bernie Melzer, Samantha M. Thomas, Pamela S. Douglas, Michel G. Khouri & Neil D. Eves. (2016) Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy. The Oncologist 21:2, pages 141-149.
Crossref
Angela Y. Higgins, Thomas D. O’Halloran & James D. Chang. (2015) Chemotherapy-induced cardiomyopathy. Heart Failure Reviews 20:6, pages 721-730.
Crossref
Shuang Guo & Serena Wong. (2014) Cardiovascular Toxicities from Systemic Breast Cancer Therapy. Frontiers in Oncology 4.
Crossref
Bonnie KyPimprapa VejpongsaEdward T.H. YehThomas ForceJavid J. Moslehi. (2013) Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies. Circulation Research 113:6, pages 754-764.
Crossref
Jessica M. Scott, Graeme J. Koelwyn, Michel G. Khouri, Pamela S. Douglas & Lee W. Jones. (2013) Preventing Cardiovascular Complications of Breast Cancer Treatment: The Utility of Effective Exercise Prescription. Current Cardiovascular Risk Reports 7:4, pages 275-282.
Crossref
T. M. Suter & M. S. Ewer. (2012) Cancer drugs and the heart: importance and management. European Heart Journal 34:15, pages 1102-1111.
Crossref
Margot Davis & Ronald M. Witteles. (2013) Cardiac Testing to Manage Cardiovascular Risk in Cancer Patients. Seminars in Oncology 40:2, pages 147-155.
Crossref
Martin ŠtěrbaOlga PopelováAnna VávrováEduard JirkovskýPetra KovaříkováVladimír GeršlTomáš Šimůnek. (2013) Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants & Redox Signaling 18:8, pages 899-929.
Crossref
Sandra M. SwainMichael S. EwerJavier CortésDino AmadoriDavid MilesAdam KnottEmma ClarkMark C. BenyunesGraham RossJosé Baselga. (2013) Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. The Oncologist 18:3, pages 257-264.
Crossref
P Vejpongsa & E T H Yeh. (2013) Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity. Clinical Pharmacology & Therapeutics 95:1, pages 45-52.
Crossref
Varsha G. Desai, Eugene H. Herman, Carrie L. Moland, William S. Branham, Sherry M. Lewis, Kelly J. Davis, Nysia I. George, Taewon Lee, Susan Kerr & James C. Fuscoe. (2013) Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model. Toxicology and Applied Pharmacology 266:1, pages 109-121.
Crossref
Irene Braña, Esther Zamora & Josep Tabernero. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 483 530 .
Michel G. KhouriPamela S. DouglasJohn R. MackeyMiguel MartinJessica M. ScottMarielle Scherrer-CrosbieLee W. Jones. (2012) Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer. Circulation 126:23, pages 2749-2763.
Crossref
Vânius Vinícius Dipe, André Tadeu Gotardo, Mitsue Haraguchi & Silvana Lima Górniak. (2012) Mimosine and cyclophosphamide: a potential new combination therapy used to prevent tumor development. Brazilian Archives of Biology and Technology 55:6, pages 871-876.
Crossref
Judith Maresch, Sebastian F. Schoppmann, Christiane M.R. Thallinger, Christoph C. Zielinski & Michael Hejna. (2012) Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment. Critical Reviews in Oncology/Hematology 82:3, pages 310-322.
Crossref
Jeanne M. DeCara. (2012) Early Detection of Chemotherapy-Related Left Ventricular Dysfunction. Current Cardiology Reports 14:3, pages 334-341.
Crossref
David Montaigne, Christopher Hurt & Remi Neviere. (2012) Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies. Biochemistry Research International 2012, pages 1-12.
Crossref
Stefano Tonioni, Carlo Gonnella & Emiliano Pica. 2012. Sports Cardiology. Sports Cardiology 119 124 .
Vishnu Chintalgattu & Aarif Y. Khakoo. 2012. Translational Cardiology. Translational Cardiology 291 316 .
S Romano, S Fratini, E Ricevuto, V Procaccini, G Stifano, M Mancini, M Di Mauro, C Ficorella & M Penco. (2011) Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. British Journal of Cancer 105:11, pages 1663-1668.
Crossref
Michael S. Ewer, Daniel D. Von Hoff & Robert S. Benjamin. (2011) A Historical Perspective of Anthracycline Cardiotoxicity. Heart Failure Clinics 7:3, pages 363-372.
Crossref
Eliza A. Hawkes, Alicia F.C. Okines, Chris Plummer & David Cunningham. (2011) Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible. Journal of Clinical Oncology 29:18, pages e560-e562.
Crossref
Elżbieta Senkus & Jacek Jassem. (2011) Cardiovascular effects of systemic cancer treatment. Cancer Treatment Reviews 37:4, pages 300-311.
Crossref
Massimo Fioranelli & Gaetano FrajeseStefano Tonioni, Carlo Gonnella & Emiliano Pica. 2011. Cardiologia dello Sport. Cardiologia dello Sport 123 127 .
Michael S. Ewer & Steven M. Ewer. (2010) Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nature Reviews Cardiology 7:10, pages 564-575.
Crossref
Douglas B. Sawyer, Xuyang Peng, Billy Chen, Laura Pentassuglia & Chee Chew Lim. (2010) Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?. Progress in Cardiovascular Diseases 53:2, pages 105-113.
Crossref
Alicia F.C. Okines & David Cunningham. (2010) Trastuzumab in gastric cancer. European Journal of Cancer 46:11, pages 1949-1959.
Crossref
Michael S. Ewer & Thomas M. Suter. 2010. Cardiotoxicity of Non-Cardiovascular Drugs. Cardiotoxicity of Non-Cardiovascular Drugs 201 221 .
S. Guiu, B. Coudert, L. Favier, L. Arnould & P. Fumoleau. (2010) Thérapeutiques dans le cancer du sein métastatique HER2-positif : présent et futur. Bulletin du Cancer 97:3, pages 365-383.
Crossref
Gerald Roul, Cyril Cohen & Ari Lieber. (2009) Cardiopathie aux anthracyclines. La Presse Médicale 38:6, pages 987-994.
Crossref
Edith A. Perez. (2008) Cardiac Toxicity of ErbB2-Targeted Therapies: What Do We Know?. Clinical Breast Cancer 8, pages S114-S120.
Crossref
Leslie T. Cooper, Kenneth L. Baughman, Arthur M. Feldman, Andrea Frustaci, Mariell Jessup, Uwe Kuhl, Glenn N. Levine, Jagat Narula, Randall C. Starling, Jeffrey Towbin & Renu Virmani. (2007) The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease. Circulation 116:19, pages 2216-2233.
Crossref
Leslie T. Cooper, Kenneth L. Baughman, Arthur M. Feldman, Andrea Frustaci, Mariell Jessup, Uwe Kuhl, Glenn N. Levine, Jagat Narula, Randall C. Starling, Jeffrey Towbin & Renu Virmani. (2007) The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease. Journal of the American College of Cardiology 50:19, pages 1914-1931.
Crossref
A M E Bruynzeel, H W M Niessen, J G F Bronzwaer, J J M van der Hoeven, J Berkhof, A Bast, W J F van der Vijgh & C J van Groeningen. (2007) The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study. British Journal of Cancer 97:8, pages 1084-1089.
Crossref
Tamar Safra. (2007) Chemotherapeutics and cardiac toxicity: treatment considerations and management strategies. Community Oncology 4:9, pages 540-548.
Crossref
Christian Zuppinger, Francesco Timolati & Thomas M. Suter. (2007) Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovascular Toxicology 7:2, pages 61-66.
Crossref
Valentina Guarneri, Daniel J. Lenihan, Vicente Valero, Jean-Bernard Durand, Kristine Broglio, Kenneth R. Hess, Laura Boehnke Michaud, Ana M. Gonzalez-Angulo, Gabriel N. Hortobagyi & Francisco J. Esteva. (2006) Long-Term Cardiac Tolerability of Trastuzumab in Metastatic Breast Cancer: The M.D. Anderson Cancer Center Experience. Journal of Clinical Oncology 24:25, pages 4107-4115.
Crossref
J. Kilo, G. Laufer & H. Antretter. (2006) Endomyocardial biopsy - jugular/subclavian vein approach. Multimedia Manual of Cardio-Thoracic Surgery 2006:1110.
Crossref
Daphne M. Coutroubis & Jeremy P. C. Steele. 2006. Tumors of the Chest. Tumors of the Chest 389 399 .
Michael S. Ewer, Mary T. Vooletich, Jean-Bernard Durand, Myrshia L. Woods, Joseph R. Davis, Vicente Valero & Daniel J. Lenihan. (2005) Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment. Journal of Clinical Oncology 23:31, pages 7820-7826.
Crossref
Michael S. Ewer & Scott M. Lippman. (2005) Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity. Journal of Clinical Oncology 23:13, pages 2900-2902.
Crossref
Michael S. Ewer, Francis J. Martin, I. Craig Henderson, Charles L. Shapiro, Robert S. Benjamin & Alberto A. Gabizon. (2004) Cardiac safety of liposomal anthracyclines. Seminars in Oncology 31, pages 161-181.
Crossref
Joseph A. Sparano, David L. Brown & Antonio C. Wolff. (2002) Predicting Cancer Therapy???Induced Cardiotoxicity. Drug Safety 25:5, pages 301-311.
Crossref
F.A. Holmes, V. alero, R.S. Walters, R.L. Theriault, D.J. Booser, H. Gibbs, G. Fraschini, A.U. Buzdar, J. Willey, D. Frye, L. Asmar & G.N. Hortobagyi. (1999) Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results. Annals of Oncology 10:4, pages 403-411.
Crossref
Joseph Swafford & Harry R. Gibbs. (1998) CARDIAC COMPLICATIONS OF CANCER TREATMENT. Anesthesiology Clinics of North America 16:3, pages 597-604.
Crossref
Julia Calzas, Pilar Lianes & Hernán Cortés-Funes. (1998) Corazón y neoplasias. Revista Española de Cardiología 51:4, pages 314-331.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.